Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure.
Cornovus Pharmaceuticals has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
Cornovus Pharmaceuticals is headquartered in Farmington, United States.
Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure.
Cornovus Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cornovus Pharmaceuticals — Funding & Investors." VCBacked, January 26, 2024, https://www.vcbacked.co/company/cornovus-pharmaceuticals. Accessed August 16, 2026.
VCBacked. (2024). Cornovus Pharmaceuticals — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/cornovus-pharmaceuticals
{{cite web |title=Cornovus Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/cornovus-pharmaceuticals |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated